We recently published a list of These 10 Stocks Were Wednesday’s Worst Performers. In this article, we are going to take a ...

The company credited much of that growth to higher generic sales around the world plus the continued strength of branded drugs Austedo, Uzedy and Ajovy. As for 2025, Teva expects to generate sales ...

Teva's Generic and Branded Drug Business Is Growing ... including cholesterol drug Lipitor, Viagra, antidepressant Zoloft, Lyrica, Influvac, and Norvasc for hypertension and chest pain.

Teva Pharmaceutical is one of the leading global generic drug manufacturers. By our estimate, roughly 70% of its total sales are derived from generics and off-patent branded drugs. Generic drugs ...

led by higher sales of generic medicines, migraine drug Ajovy, Huntington's treatment Austedo and its schizophrenia drug Uzedy. Teva forecast 2025 revenue of $16.8 billion to $17.4 billion and ...

Shares of Catalyst Pharmaceuticals rose as the company reached a settlement agreement with Teva Pharmaceuticals related to Teva's plans for a generic version of Firdapse 10 mg tablets. Catalyst ...